Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 84Gynecologic 9Gastrointestinal 9Genitourinary 6Head & Neck 5Thoracic 3Sarcoma 3Dermatologic 3CNS 3Plasma cell 2Other hematologic neoplasm 2Lymphoid 2Other 1NET 1Myeloid 1Endocrine 1

Conditions

Neuroendocrine Tumors 3Pheochromocytoma 2Paraganglioma 2Neoplasm Metastasis 2Uveal Melanoma 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Endometrial Stromal 1Pancreatic Neoplasms 1Melanoma 1Lung Neoplasms 1Carcinoma, Neuroendocrine 1Breast Neoplasms 1Adrenocortical Carcinoma 1Adrenocortical Adenoma 1Adenoma, Islet Cell 1Adenocarcinoma of Lung 1

Interventions

selpercatinib 3Fulvestrant 3Fluorodeoxyglucose F18 3ribociclib 2Trastuzumab 2Magnetic Resonance Spectroscopy 2Letrozole 2Cyclophosphamide 2Alpelisib 2vandetanib 1tivozanib 1tipifarnib 1temsirolimus 1romidepsin 1pembrolizumab 1gadoteridol 1gadoterate meglumine 1gadolinium ethoxybenzyl DTPA 1gadodiamide 1gadobutrol 1gadobenic acid 1fludarabine phosphate 1fludarabine 1exemestane 1entrectinib 1entinostat 1avelumab 1atezolizumab 1alectinib 1aldesleukin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Biopsy × Endocrine × Clear all
NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Stanford University

Phase 1 Recruiting
18 enrolled
BreastCNSDermatologicEndocrineHead & NeckNETThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡